Site icon pharmaceutical daily

Global Topical Dispenser Market (2020 to 2025) – by Product, Application, End-user and Geography – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Topical Dispenser Market (2020-2025) by Product, Application, End user, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.

The Global Topical Dispenser Market is estimated to be USD 441.38 Mn in 2020 and is expected to reach USD 593.45 Mn by 2025, growing at a CAGR of 6.1%.

Increase in the prevalence of skin infections and diseases and Rising demand for topical applicators is driving the market.

Limited Awareness for the usage of topical dispenser is hindering the market. Preference for alternative modes of drug delivery has created challenges for the market players. Delivery of biologics through the transdermal route and Self-administration and home care have created opportunities for the market.

Companies Mentioned

Recent Developments

1. In August 2019, DoseLogix announced a partnership with B&B Pharmaceuticals, Inc. This partnership will help DoseLogix to increase its product sales in the future.

2. In December 2018, Cipher Pharmaceuticals Inc. (Canada) received acceptance for its “A-101 40% topical solution” for the Health Canada review. This product is prescribed to treat advanced seborrheic keratosis, a commonly occurring non-cancerous skin growth that affects more than 9 million Canadian adults.

3. In December 2018, GlaxoSmithKline (UK) invested USD 36.0 million in manufacturing facilities in Canada to produce and distribute its best topical pain reliever – VOLTAREN.

Why buy this report?

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Overview

4.1 Introduction

4.2 Market Dynamics

4.2.1 Drivers

4.2.1.1 Increase in the prevalence of skin infections and diseases

4.2.1.2 Rising demand for topical applicators

4.2.2 Restraints

4.2.2.1 Limited Awareness

4.2.3 Opportunities

4.2.3.1 Delivery of biologics through the transdermal route

4.2.3.2 Self-administration and home care

4.2.4 Challenges

4.2.4.1 Preference for alternative modes of drug delivery

4.3 Trends

5 Market Analysis

5.1 Porter’s Five Forces Analysis

5.2 Impact of COVID-19

5.3 Ansoff Matrix Analysis

6 Global Topical Dispenser Market, By Product

6.1 Semi-Solid Formulations

6.1.1 Creams

6.1.2 Ointments

6.1.3 Lotions

6.1.4 Gels

6.1.5 Pastes

6.2 Liquid Formulations

6.2.1 Solutions

6.2.2 Suspensions

6.3 Solid Formulations

6.3.1 Powders

6.3.2 Suppositories

6.4 Transdermal Products

6.4.1 Transdermal Patches

6.4.2 Transdermal Semi-solids

7 Global Topical Dispenser Market, By Application

7.1 Introduction

7.2 Metered Topical Dispensers

7.3 Swab Topical Dispensers

8 Global Topical Dispenser Market, By End User

8.1 Introduction

8.2 Home Care Settings

8.3 Hospitals & Clinics

8.4 Burn Centres

8.5 Other Facilities

9 Global Topical Dispenser Market, By Geography

9.1 Introduction

9.2 North America

9.2.1 US

9.2.2 Canada

9.2.3 Mexico

9.3 South America

9.3.1 Brazil

9.3.2 Argentina

9.4 Europe

9.4.1 UK

9.4.2 France

9.4.3 Germany

9.4.4 Italy

9.4.5 Spain

9.4.6 Rest of Europe

9.5 Asia-Pacific

9.5.1 China

9.5.2 Japan

9.5.3 India

9.5.4 Indonesia

9.5.5 Malaysia

9.5.6 South Korea

9.5.7 Australia

9.5.8 Russia

9.5.9 Rest of APAC

9.6 Rest of the World

9.6.1 Qatar

9.6.2 Saudi Arabia

9.6.3 South Africa

9.6.4 United Arab Emirates

9.6.5 Latin America

10 Competitive Landscape

10.1 Competitive Quadrant

10.2 Market Share Analysis

10.3 Competitive Scenario

10.3.1 Mergers & Acquisitions

10.3.2 Agreement, Collaborations, & Partnerships

10.3.3 New Product Launches & Enhancements

10.3.4 Investments & Funding

11 Company Profiles

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/dbdpzr

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version